Indian Pharma Major Glenmark Announces Hocine Sidi-Said’s Exit From Board
Advertisement
Advertisement
Drug maker
Hocine has now joined Pharma International, a one of the leading generic pharmaceutical firm in Jordan, as the chief executive officer since November 2014. The company is backed by private equity and has a special focus on emerging markets.
Hocine had also founded advisory and investment firm called Bio-nAbler in 2009. Previously, he has served other pharmaceutical majors such as Moksha8 and Pfizer and has nearly 25 years of experience across emerging markets.
Hocine had joined Glenmark’s Board in December 2009.
Advertisement
Advertisement
- 2 states where home prices are falling because there are too many houses and not enough buyers
- US buys 81 Soviet-era combat aircraft from Russia's ally costing on average less than $20,000 each, report says
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- 9 health benefits of drinking sugarcane juice in summer
- 10 benefits of incorporating almond oil into your daily diet
- From heart health to detoxification: 10 reasons to eat beetroot
- Why did a NASA spacecraft suddenly start talking gibberish after more than 45 years of operation? What fixed it?
- ICICI Bank shares climb nearly 5% after Q4 earnings; mcap soars by ₹36,555.4 crore
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market